Today

Agents

Chat

Arena

Discover

More

App

Interpace Biosciences Q2 Revenue USD 9.131 Million - IDXG News | Rallies

Interpace Biosciences Q2 Revenue USD 9.131 Million

IDXG•2026-08-10

Q2 financial results

Interpace Biosciences Q2 revenue was USD 9.131 million.

Q2 operating income: USD 321 thousand
Q2 net income: USD 158 thousand
Q2 operating expenses: USD 5.332 million
Q2 gross profit: USD 5.653 million
Q2 net income from continuing operations: USD 266 thousand

Related News

Celsius Holdings Announces Leadership Changes As Part Of Organizational Realignment To Support Its Total Energy Portfolio Strategy

CELH•2026-08-10

Virginia Electric And Power Company Issues $1.25B Of 5.65% Senior Notes Due 2036

Stellex Capital becomes Team’s largest shareholder, lifts stake to about 35%

TISI•2026-08-10

Energy Transfer director James Richard Perry buys common units worth $249,992.82

ET•2026-08-10

Radian Appoints Barry C. McCarthy To Board Of Directors

RDN•2026-08-10